drugset / Trial / NCT02201381
Study of the Safety, Tolerability and Efficacy of Metabolic Combination Treatments on Cancer
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to determine the effectiveness of a regimen of selected metabolic treatments for patients with cancer in a real world setting and to conduct exploratory analysis on the relationship between the degree of response and changes in biochemical markers (such as glucose and lipid levels).
Timeline
- Start
- 2022-05-23
- Primary completion
- 2027-05-23
- Completion
- 2027-09-23
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Atorvastatin | Small molecule | 80 mg | Oral |
| Subject | Doxycycline | Small molecule | 100 mg | Oral |
| Subject | Mebendazole | Small molecule | 100 mg | Oral |
| Subject | Metformin | Small molecule | 1000 mg | Oral |